Three-dimensional echocardiography is transitioning from a research tool to clinical practice due to technological improvements, though its strengths and weaknesses must be appreciated.
Supports cautious clinical adoption of 3D echocardiography; leaves open need for prospective validation and standardization.
Over the past two to three decades echocardiography has come a considerable distance from the early M-mode machines, and has become an indispensable diagnostic tool in any cardiovascular department. It has long been proved to be safe and cost-effective, and its clinical versatility has steadily increased with the continued integration of newer techniques, such as two-dimensional and harmonic imaging, Doppler and much more. One of the more recent developments in the field is three-dimensional echocardiography (3DE). 3DE, in various forms, has been used as a research tool for many years now, but lately improvements in software and transducer technology have begun to facilitate its integration into clinical practice. As with any technique, 3DE has its strengths and weaknesses, and these must be fully appreciated if it is to be utilised effectively.
No takes yet. Share an insight, caveat, or question.
Bhan et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: